Drug intelligence / Profile preview

dialysate

Development stage: Unknown
Administration: Intraperitoneal, Extracorporeal

Overview

Dialysate is a cleansing fluid used in dialysis treatments for patients with kidney failure. It functions by drawing waste products and excess fluid from the blood. In peritoneal dialysis, dialysate flows through a catheter into the peritoneal cavity where the peritoneum acts as a filter, allowing waste products and excess fluid to pass from blood vessels into the solution. After a set dwell time, the fluid containing filtered waste is drained and discarded. In hemodialysis, dialysate works with the hemodialyzer to remove waste products from blood as it passes through the dialysis machine. The composition of dialysate can be adjusted based on patient needs, particularly regarding electrolyte levels such as potassium and magnesium.

Other names: dialysis solutioncleansing fluid

Beyond the preview

Go deeper on dialysate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on dialysate.

Explore the full profile